BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharma P, Shaheen NJ, Katzka D, Bergman JJGHM. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.Gastroenterology. 2020;158:760-769. [PMID: 31730766 DOI: 10.1053/j.gastro.2019.09.051] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Lui TKL, Tsui VWM, Leung WK. Accuracy of artificial intelligence-assisted detection of upper GI lesions: a systematic review and meta-analysis. Gastrointest Endosc. 2020;92:821-830.e9. [PMID: 32562608 DOI: 10.1016/j.gie.2020.06.034] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
2 Zhou X, Chen H, Chen M, Ding C, Zhang G, Si X. Comparison of endoscopic injection of botulinum toxin and steroids immediately after endoscopic submucosal dissection to prevent esophageal stricture: a prospective cohort study. J Cancer 2021;12:5789-96. [PMID: 34475992 DOI: 10.7150/jca.60720] [Reference Citation Analysis]
3 Grillo F, Mastracci L, Saragoni L, Vanoli A, Limarzi F, Gullo I, Ferro J, Paudice M, Parente P, Fassan M. Neoplastic and pre-neoplastic lesions of the oesophagus and gastro-oesophageal junction. Pathologica 2020;112:138-52. [PMID: 33179618 DOI: 10.32074/1591-951X-164] [Reference Citation Analysis]
4 Schmidt M, Hackett RJ, Baker AM, McDonald SAC, Quante M, Graham TA. Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34728819 DOI: 10.1038/s41575-021-00531-4] [Reference Citation Analysis]
5 Sullivan R, Mulki R, Peter S. The role of ablation in the treatment of dysplastic Barrett's esophagus. Ther Adv Gastrointest Endosc 2021;14:26317745211049967. [PMID: 34708203 DOI: 10.1177/26317745211049967] [Reference Citation Analysis]
6 Faknak N, Pittayanon R, Tiankanon K, Lerttanatum N, Sanpavat A, Klaikaew N, Rerknimitr R. Performance status of targeted biopsy alone versus Sydney protocol by non-NBI expert gastroenterologist in gastric intestinal metaplasia diagnosis. Endosc Int Open 2022;10:E273-9. [DOI: 10.1055/a-1783-9081] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ali S, Bailey A, Ash S, Haghighat M, Leedham SJ, Lu X, East JE, Rittscher J, Braden B; TGU Investigators. A Pilot Study on Automatic Three-Dimensional Quantification of Barrett's Esophagus for Risk Stratification and Therapy Monitoring. Gastroenterology 2021;161:865-878.e8. [PMID: 34116029 DOI: 10.1053/j.gastro.2021.05.059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Puthenpura MM, Sanaka KO, Qin Y, Thota PN. Management of nondysplastic Barrett’s esophagus: When to survey? When to ablate? Therapeutic Advances in Chronic Disease 2022;13:204062232210867. [DOI: 10.1177/20406223221086760] [Reference Citation Analysis]
9 van der Wel MJ, Klaver E, Pouw RE, Brosens LAA, Biermann K, Doukas M, Huysentruyt C, Karrenbeld A, Ten Kate FJW, Kats-Ugurlu G, van der Laan J, van Lijnschoten I, Moll FCP, Offerhaus GJA, Ooms AHAG, Seldenrijk CA, Visser M, Tijssen JG, Meijer SL, Bergman JJGHM. Significant variation in histopathological assessment of endoscopic resections for Barrett's neoplasia suggests need for consensus reporting: propositions for improvement. Dis Esophagus 2021:doab034. [PMID: 34100554 DOI: 10.1093/dote/doab034] [Reference Citation Analysis]
10 Cummings D, Wong J, Palm R, Hoffe S, Almhanna K, Vignesh S. Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors. Cancers (Basel) 2021;13:582. [PMID: 33540736 DOI: 10.3390/cancers13030582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Staudenmann DA, Skacel EP, Tsoutsman T, Kaffes AJ, Saxena P. Safety and long-term efficacy of hybrid-argon plasma coagulation for the treatment of Barrett's esophagus: An Australian pilot study (with video). Int J Gastrointest Interv 2021;10:128-32. [DOI: 10.18528/ijgii200050] [Reference Citation Analysis]
12 Chang K, Jackson CS, Vega KJ. Barrett's Esophagus: Diagnosis, Management, and Key Updates. Gastroenterol Clin North Am 2021;50:751-68. [PMID: 34717869 DOI: 10.1016/j.gtc.2021.08.009] [Reference Citation Analysis]
13 Agarwal S, Alshelleh M, Scott J, Dhaliwal L, Codipilly DC, Dierkhising R, Leggett CL, Wang KK, Otaki FA, Trindade AJ, Iyer PG. Comparative outcomes of radiofrequency ablation and cryoballoon ablation in dysplastic Barrett's esophagus: a propensity score-matched cohort study. Gastrointest Endosc 2021:S0016-5107(21)01694-1. [PMID: 34624303 DOI: 10.1016/j.gie.2021.09.037] [Reference Citation Analysis]
14 Nguyen TH, Thrift AP, Ketwaroo GA, Du XL, Leon Novelo L, George R, Rosen DG, El-Serag HB. External validation of a model determining risk of neoplastic progression of Barrett's esophagus in a cohort of U.S. veterans. Gastrointest Endosc 2022:S0016-5107(22)00002-5. [PMID: 34998796 DOI: 10.1016/j.gie.2021.12.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Wei MT, Friedland S. Early Esophageal Cancer: What the Gastroenterologist Needs to Know. Gastroenterol Clin North Am 2021;50:791-808. [PMID: 34717871 DOI: 10.1016/j.gtc.2021.07.004] [Reference Citation Analysis]
16 Fitzgerald RC, di Pietro M, O'Donovan M, Maroni R, Muldrew B, Debiram-Beecham I, Gehrung M, Offman J, Tripathi M, Smith SG, Aigret B, Walter FM, Rubin G, Sasieni P; BEST3 Trial team. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. Lancet 2020;396:333-44. [PMID: 32738955 DOI: 10.1016/S0140-6736(20)31099-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 20] [Article Influence: 21.0] [Reference Citation Analysis]
17 Bowman CJ, Zhang R, Balitzer D, Wang D, Rabinovitch PS, Kővári BP, Mattis AN, Kakar S, Lauwers GY, Choi WT. Persistent or recurrent Barrett's neoplasia after an endoscopic therapy session is associated with DNA content abnormality and can be detected by DNA flow cytometric analysis of paraffin-embedded tissue. Mod Pathol 2021. [PMID: 34108638 DOI: 10.1038/s41379-021-00832-8] [Reference Citation Analysis]
18 Dhaliwal A, Saghir SM, Mashiana HS, Braseth A, Dhindsa BS, Ramai D, Taunk P, Gomez-Esquivel R, Dam A, Klapman J, Adler DG. Endoscopic cryotherapy: Indications, techniques, and outcomes involving the gastrointestinal tract. World J Gastrointest Endosc 2022; 14(1): 17-28 [DOI: 10.4253/wjge.v14.i1.17] [Reference Citation Analysis]
19 Kolb JM, Wani S. Endoscopic Management of Barrett's Esophagus. Dig Dis Sci 2022. [PMID: 35226224 DOI: 10.1007/s10620-022-07395-x] [Reference Citation Analysis]
20 Kubota D, Sakaguchi Y, Nagao S, Tsuji Y, Fujishiro M. Subtotal esophageal endoscopic submucosal dissection for long-segment Barrett's esophagus and adenocarcinoma. Endoscopy 2021. [PMID: 34933367 DOI: 10.1055/a-1704-7548] [Reference Citation Analysis]
21 Konda VJA. Shining a light on the monsters under the bed. Gastrointest Endosc 2021;94:22-3. [PMID: 33926712 DOI: 10.1016/j.gie.2021.01.037] [Reference Citation Analysis]
22 Rouphael C, Anil Kumar M, Sanaka MR, Thota PN. Indications, contraindications and limitations of endoscopic therapy for Barrett's esophagus and early esophageal adenocarcinoma. Therap Adv Gastroenterol 2020;13:1756284820924209. [PMID: 32523628 DOI: 10.1177/1756284820924209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Bolger JC, Donohoe CL, Lowery M, Reynolds JV. Advances in the curative management of oesophageal cancer. Br J Cancer 2021. [PMID: 34675397 DOI: 10.1038/s41416-021-01485-9] [Reference Citation Analysis]
24 Dam AN, Klapman J. A narrative review of Barrett's esophagus in 2020, molecular and clinical update.Ann Transl Med. 2020;8:1107. [PMID: 33145326 DOI: 10.21037/atm-20-4406] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Wang Y, Ma B, Yang S, Li W, Li P. Efficacy and Safety of Radiofrequency Ablation vs. Endoscopic Surveillance for Barrett’s Esophagus With Low-Grade Dysplasia: Meta-Analysis of Randomized Controlled Trials. Front Oncol 2022;12:801940. [DOI: 10.3389/fonc.2022.801940] [Reference Citation Analysis]
26 Correia ACP, Straub D, Calpe S, Krishnadath KK. Novel In Vivo Mouse Cryoablation Model to Explore Unique Therapeutic Approaches for Premalignant Columnar Lesions. Methods Protoc 2021;4:6. [PMID: 33526760 DOI: 10.3390/mps4010006] [Reference Citation Analysis]
27 Um PS, Chan MQ, Hinton A, Haisley K, Perry KA, Balasubramanian G. Adherence to Surveillance Endoscopies Posteradication of Barrett's Esophagus With High-grade Dysplasia or Carcinoma In Situ. J Clin Gastroenterol 2022. [PMID: 35389913 DOI: 10.1097/MCG.0000000000001701] [Reference Citation Analysis]
28 Jones B, Wani S. Endoscopic Eradication Therapy for Barrett's Neoplasia: Where Do We Stand a Decade Later? Curr Gastroenterol Rep 2020;22:61. [PMID: 33277663 DOI: 10.1007/s11894-020-00799-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Furnari M, Telese A, Hann A, Lisotti A, Boškoski I, Eusebi LH. New Devices for Endoscopic Treatments in Gastroenterology: A Narrative Review. Curr Drug Metab 2020;21:850-65. [PMID: 32703127 DOI: 10.2174/1389200221666200722145727] [Reference Citation Analysis]
30 Hamade N, Kamboj AK, Krishnamoorthi R, Singh S, Hassett LC, Katzka DA, Kahi CJ, Fatima H, Iyer PG. Systematic review with meta-analysis: neoplasia detection rate and post-endoscopy Barrett's neoplasia in Barrett's oesophagus. Aliment Pharmacol Ther 2021;54:546-59. [PMID: 34275161 DOI: 10.1111/apt.16531] [Reference Citation Analysis]
31 Dumoulin FL, Rodriguez-monaco FD, Ebigbo A, Steinbrück I. Artificial Intelligence in the Management of Barrett’s Esophagus and Early Esophageal Adenocarcinoma. Cancers 2022;14:1918. [DOI: 10.3390/cancers14081918] [Reference Citation Analysis]
32 Marques de Sá I, Pereira AD, Sharma P, Dinis-Ribeiro M. Systematic review of the published guidelines on Barrett's esophagus: should we stress the consensus or the differences? Dis Esophagus 2020:doaa115. [PMID: 33249488 DOI: 10.1093/dote/doaa115] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Garman KS. Drivers of Esophageal Adenocarcinoma and Opportunities for Cancer Interception. Cell Mol Gastroenterol Hepatol 2021;12:787-8. [PMID: 34029533 DOI: 10.1016/j.jcmgh.2021.04.018] [Reference Citation Analysis]
34 Codipilly DC, Krishna Chandar A, Wang KK, Katzka DA, Goldblum JR, Thota PN, Falk GW, Chak A, Iyer PG. Wide-area transepithelial sampling for dysplasia detection in Barrett's esophagus: a systematic review and meta-analysis. Gastrointest Endosc 2021:S0016-5107(21)01646-1. [PMID: 34543648 DOI: 10.1016/j.gie.2021.09.015] [Reference Citation Analysis]
35 Huang Q, Read M, Gold JS, Zou XP. Unraveling the identity of gastric cardiac cancer. J Dig Dis 2020;21:674-86. [PMID: 32975049 DOI: 10.1111/1751-2980.12945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Wang AY, Hwang JH, Bhatt A, Draganov PV. AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States: Commentary. Gastroenterology 2021;161:2030-2040.e1. [PMID: 34689964 DOI: 10.1053/j.gastro.2021.08.058] [Reference Citation Analysis]
37 McGoran JJ, Ragunath K. Endoscopic management of Barrett's esophagus: Western perspective of current status and future prospects. Dig Endosc 2021;33:720-9. [PMID: 32790886 DOI: 10.1111/den.13812] [Reference Citation Analysis]
38 Dumoulin FL, Hildenbrand R, Oyama T, Steinbrück I. Current Trends in Endoscopic Diagnosis and Treatment of Early Esophageal Cancer. Cancers (Basel) 2021;13:752. [PMID: 33670208 DOI: 10.3390/cancers13040752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Condon A, Muthusamy VR. The evolution of endoscopic therapy for Barrett's esophagus. Ther Adv Gastrointest Endosc 2021;14:26317745211051834. [PMID: 34708204 DOI: 10.1177/26317745211051834] [Reference Citation Analysis]
40 Badgery H, Read M, Winter NN, Taylor ACF, Hii MW. The role of esophagectomy in the management of Barrett's esophagus with high-grade dysplasia. Ann N Y Acad Sci 2020;1481:72-89. [PMID: 32812261 DOI: 10.1111/nyas.14439] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Barret M, Pioche M, Terris B, Ponchon T, Cholet F, Zerbib F, Chabrun E, Le Rhun M, Coron E, Giovannini M, Caillol F, Laugier R, Jacques J, Legros R, Boustiere C, Rahmi G, Metivier-Cesbron E, Vanbiervliet G, Bauret P, Escourrou J, Branche J, Jilet L, Abdoul H, Kaddour N, Leblanc S, Bensoussan M, Prat F, Chaussade S. Endoscopic radiofrequency ablation or surveillance in patients with Barrett's oesophagus with confirmed low-grade dysplasia: a multicentre randomised trial. Gut 2021;70:1014-22. [PMID: 33685969 DOI: 10.1136/gutjnl-2020-322082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Zagari RM, Eusebi LH, Galloro G, Rabitti S, Neri M, Pasquale L, Bazzoli F. Attending Training Courses on Barrett's Esophagus Improves Adherence to Guidelines: A Survey from the Italian Society of Digestive Endoscopy. Dig Dis Sci 2021;66:2888-96. [PMID: 32984930 DOI: 10.1007/s10620-020-06615-6] [Reference Citation Analysis]
43 Vosko S, Gupta S, Shahidi N, Hourigan LF, van Hattem WA, Bar-Yishay I, Schoeman S, Sidhu M, Burgess NG, Lee EYT, Bourke MJ. Snare-tip soft coagulation is effective and efficient as a first-line modality for treating intraprocedural bleeding during Barrett's mucosectomy. Endoscopy 2021;53:511-6. [PMID: 32659800 DOI: 10.1055/a-1218-6089] [Reference Citation Analysis]
44 Axley P, Mitchell R, Council L, Patel C, Tracht J, Collingwood R, Harrison D, Redden D, Beasely M, Kabir Baig KKR, Al Diffalha S, Peter S. Videoconference microscopy is a reliable alternative to conventional microscopy in the evaluation of Barrett's esophagus: Zooming into a new era. Dis Esophagus 2021:doab064. [PMID: 34553220 DOI: 10.1093/dote/doab064] [Reference Citation Analysis]
45 Kolb JM, Wani S. Endoscopic eradication therapy for Barrett's oesophagus: state of the art. Curr Opin Gastroenterol 2020;36:351-8. [PMID: 32487852 DOI: 10.1097/MOG.0000000000000650] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Hasan Y, Murali AR, Gerke H. Endoscopic mucosal resection for early esophageal carcinoma is effective and safe but necessitates continued surveillance. Indian J Gastroenterol 2020;39:487-94. [PMID: 33201442 DOI: 10.1007/s12664-020-01084-1] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Bakhos CT, Acevedo E Jr, Petrov RV, Abbas AE. Surveillance Following Treatment of Esophageal Cancer. Surg Clin North Am 2021;101:499-509. [PMID: 34048769 DOI: 10.1016/j.suc.2021.03.011] [Reference Citation Analysis]
48 Swart N, Maroni R, Muldrew B, Sasieni P, Fitzgerald RC, Morris S; BEST3 Consortium. Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data. EClinicalMedicine 2021;37:100969. [PMID: 34195582 DOI: 10.1016/j.eclinm.2021.100969] [Reference Citation Analysis]
49 Farina DA, Condon A, Komanduri S, Muthusamy VR. A Practical Approach to Refractory and Recurrent Barrett's Esophagus. Gastrointest Endosc Clin N Am 2021;31:183-203. [PMID: 33213795 DOI: 10.1016/j.giec.2020.09.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 van Munster S, Nieuwenhuis E, Weusten BLAM, Alvarez Herrero L, Bogte A, Alkhalaf A, Schenk BE, Schoon EJ, Curvers W, Koch AD, van de Ven SEM, de Jonge PJF, Tang TJ, Nagengast WB, Peters FTM, Westerhof J, Houben MHMG, Bergman JJ, Pouw RE; Dutch Barrett Expert Centers. Long-term outcomes after endoscopic treatment for Barrett's neoplasia with radiofrequency ablation ± endoscopic resection: results from the national Dutch database in a 10-year period. Gut 2021:gutjnl-2020-322615. [PMID: 33753417 DOI: 10.1136/gutjnl-2020-322615] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Molena D, Demeester SR. When less is just less: endoscopic therapy for submucosal T1b esophageal cancer. Gastrointestinal Endoscopy 2020;92:40-3. [DOI: 10.1016/j.gie.2020.03.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Mathies D, Oyama T, Steinbrück I, Dumoulin FL. Topical oro-dispersible budesonide tablets for stricture prevention after near circumferential ESD for esophageal squamous cell cancer - a case report. Z Gastroenterol 2021;59:454-6. [PMID: 33735916 DOI: 10.1055/a-1409-1076] [Reference Citation Analysis]
53 Hollenbach M, Feisthammel J, Hoffmeister A. [Interventional endoscopy in the gastrointestinal tract : Indications and limitations]. Internist (Berl) 2020;61:1017-30. [PMID: 32748102 DOI: 10.1007/s00108-020-00845-6] [Reference Citation Analysis]
54 Srinivasan S, Sharma P. Real-world data for endoscopic therapy in LGD: not looking so good. Gut 2021:gutjnl-2021-324544. [PMID: 34330785 DOI: 10.1136/gutjnl-2021-324544] [Reference Citation Analysis]
55 Yang H, Hu B. Recent advances in early esophageal cancer: diagnosis and treatment based on endoscopy. Postgrad Med 2021;133:665-73. [PMID: 34030580 DOI: 10.1080/00325481.2021.1934495] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
56 Correia FP, Lourenço LC. Artificial intelligence application in diagnostic gastrointestinal endoscopy - Deus ex machina? World J Gastroenterol 2021; 27(32): 5351-5361 [PMID: 34539137 DOI: 10.3748/wjg.v27.i32.5351] [Reference Citation Analysis]
57 Choi WT, Lauwers GY, Montgomery EA. Utility of ancillary studies in the diagnosis and risk assessment of Barrett's esophagus and dysplasia. Mod Pathol 2022. [PMID: 35260826 DOI: 10.1038/s41379-022-01056-0] [Reference Citation Analysis]
58 Ponsky JL, Strong AT. A History of Flexible Gastrointestinal Endoscopy. Surg Clin North Am 2020;100:971-92. [PMID: 33128891 DOI: 10.1016/j.suc.2020.08.013] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]